News from neurelis, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 11, 2014, 08:00 ET

Neurelis Regains Rights to Intranasal Diazepam Program

Neurelis, Inc. ("Neurelis") today announced an agreement with Biotie Therapies Corp. ("Biotie") to end the option held by Biotie to purchase...

Jun 04, 2013, 11:27 ET

Neurelis Enters into Option and Merger Agreement with Biotie Therapies

Neurelis, Inc. ("Neurelis") today announced an agreement with Biotie Therapies Corp. ("Biotie") to further develop NRL-1 (intranasal diazepam) and...

Feb 06, 2012, 15:50 ET

Neurelis Announces FDA Allowance of IND Application for NRL-1, a Novel Intranasal Diazepam Formulation

  Neurelis, Inc. today announced that the United States Food and Drug Administration (FDA) has cleared an Investigational New Drug...

Jun 14, 2011, 13:37 ET

Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)

Neurelis, Inc. today announced the results of a randomized crossover study in healthy volunteers assessing diazepam pharmacokinetics and...

Apr 20, 2011, 09:00 ET

Neurelis Announces Completion of Dosing in Study of Intranasal Diazepam

Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and...